Lactobacillus fermentum BR11 and fructo-oligosaccharide partially reduce jejunal inflammation in a model of intestinal mucositis in rats (Q46249623)

20 December 2017

title

Lactobacillus fermentum BR11 and fructo-oligosaccharide partially reduce jejunal inflammation in a model of intestinal mucositis in rats (English)

1 reference

20 December 2017

0 references

1 reference

Lactobacillus fermentum

object named as

Lactobacillus fermentum

1 reference

2

1 reference

20 December 2017

author name string

Cassie L Smith

1

1 reference

20 December 2017

Roger Yazbeck

3

1 reference

20 December 2017

Diana M Torres

4

1 reference

20 December 2017

Ross N Butler

5

1 reference

20 December 2017

Gordon S Howarth

6

1 reference

20 December 2017

publication date

1 January 2008

1 reference

20 December 2017

published in

Nutrition and Cancer

1 reference

20 December 2017

volume

60

1 reference

20 December 2017

issue

6

1 reference

20 December 2017

page(s)

757-767

1 reference

20 December 2017

Oral and intestinal mucositis — causes and possible treatments

cites work

1 reference

https://api.crossref.org/works/10.1080%2F01635580802192841

Perspectives on cancer therapy-induced mucosal injury: pathogenesis, measurement, epidemiology, and consequences for patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635580802192841

The molecular immunology of mucositis: implications for evidence-based research in alternative and complementary palliative treatments

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635580802192841

Chemotherapy for cancer causes apoptosis that precedes hypoplasia in crypts of the small intestine in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635580802192841

Aetiology of inflammatory bowel disease (IBD): role of intestinal microbiota and gut-associated lymphoid tissue immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635580802192841

Lactobacillus GG in inducing and maintaining remission of Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635580802192841

Modulation of the effect of dextran sulfate sodium-induced acute colitis by the administration of different probiotic strains of Lactobacillus and Bifidobacterium.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635580802192841

Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635580802192841

Inflammatory bowel disease: current insights into pathogenesis and new therapeutic options; probiotics, prebiotics and synbiotics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635580802192841

Once daily high dose probiotic therapy (VSL#3) for maintaining remission in recurrent or refractory pouchitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635580802192841

Probiotics: their role in the treatment and prevention of disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635580802192841

Probiotics, prebiotics and synbiotics: a role in chemoprevention for colorectal cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635580802192841

Probiotic bacterium prevents cytokine-induced apoptosis in intestinal epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635580802192841

Nutritional advantages of probiotics and prebiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635580802192841

Using probiotics and prebiotics to improve gut health

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635580802192841

Role of anaerobic bacteria in the metabolic welfare of the colonic mucosa in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635580802192841

Prebiotics and resistance to gastrointestinal infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635580802192841

Gastrointestinal effects of prebiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635580802192841

Restoration of the integrity of rat caeco-colonic mucosa by resistant starch, but not by fructo-oligosaccharides, in dextran sulfate sodium-induced experimental colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635580802192841

Short-chain fructooligosaccharides, in spite of being fermented in the upper part of the large intestine, have anti-inflammatory activity in the TNBS model of colitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635580802192841

A novel breath test for the non-invasive assessment of small intestinal mucosal injury following methotrexate administration in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635580802192841

Pre-treatment with insulin-like growth factor-I partially ameliorates 5-fluorouracil-induced intestinal mucositis in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635580802192841

Lyprinol only partially improves indicators of small intestinal integrity in a rat model of 5-fluorouracil-induced mucositis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635580802192841

Oral ingestion of streptococcus thermophilus diminishes severity of small intestinal mucositis in methotrexate treated rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635580802192841

Effects of probiotics on radiation-induced intestinal injury in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635580802192841

Immune-stimulating and gut health-promoting properties of short-chain fructo-oligosaccharides

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635580802192841

Improvement of the probiotic effect of micro-organisms by their combination with maltodextrins, fructo-oligosaccharides and polyunsaturated fatty acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635580802192841

10.1080/01635580802192841

21 January 2018

Identifiers

DOI

1 reference

20 December 2017

1 reference

20 December 2017